Persistence of the hepatitis B virus covalently closed circular DNA in HepaRG human hepatocyte-like cells

Journal of General Virology

Volumn 90, Issue 1, 2009, Pages 127-135

  Hantz, Olivier ^a,b   Parent, R ^a,b,c   Durantel, D ^a,b   Gripon, P ^d   Guguen Guillouzo, C ^d   Zoulim, F ^a,b,e  

^a INSERM   (France)

^b UNIVERSITÉ LYON 1   (France)

^c Fred Hutchinson Cancer Research Center   (United States)

^d PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^e HÔTEL DIEU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CIRCULAR DNA; LAMIVUDINE; VIRUS DNA;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DNA DETERMINATION; DRUG MECHANISM; GENE AMPLIFICATION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; LIVER CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REINFECTION; VIRUS CELL INTERACTION; VIRUS PARTICLE; VIRUS REPLICATION; VIRUS VIRULENCE; METABOLISM; PHYSIOLOGY; TUMOR CELL LINE; VIROLOGY;

HEPATITIS B VIRUS;

CELL LINE, TUMOR; DNA, CIRCULAR; DNA, VIRAL; HEPATITIS B VIRUS; HEPATOCYTES; HUMANS; VIRUS REPLICATION;

EID: 59849105037     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.004861-0     Document Type: Article

References (44)

1. Abou-Jaoude, G. & Sureau, C. (2007). Entry of hepatitis delta virus requires the conserved cysteine residues of the hepatitis B virus envelope protein antigenic loop and is blocked by inhibitors of thioldisulfide exchange. J Virol 81, 13057-13066.
2. Aninat, C., Piton, A., Glaise, D., Le Charpentier, T., Langouet, S., Morel, F., Guguen-Guillouzo, C. & Guillouzo, A. (2006). Expression of cytochromes P450, conjugating enzymes and nuclear receptors in human hepatoma HepaRG cells. Drug Metab Dispos 34, 75-83.
3. Beckel-Mitchener, A. & Summers, J. (1997). A novel transcriptional element in circular DNA monomers of the duck hepatitis B virus. J Virol 71, 7917-7922.
4. Blanchet, M. & Sureau, C. (2006). Analysis of the cytosolic domains of the hepatitis B virus envelope proteins for their function in viral particle assembly and infectivity. J Virol 80, 11935-11945.
5. Borel, C., Schorr, O., Durand, I., Zoulim, F., Kay, A., Trepo, C. & Hantz, O. (2001). Initial amplification of duck hepatitis B virus covalently closed circular DNA after in vitro infection of embryonic duck hepatocytes is increased by cell cycle progression. Hepatology 34, 168-179.
6. Bouchard, M. J. & Schneider, R. J. (2004). The enigmatic X gene of hepatitis B virus. J Virol 78, 12725-12734.
7. Chemin, I., Baginski, I., Petit, M. A., Zoulim, F., Pichoud, C., Capel, F., Hantz, O. & Trepo, C. (1991). Correlation between HBV DNA detection by polymerase chain reaction and pre-S1 antigenemia in symptomatic and asymptomatic hepatitis B virus infections. J Med Virol 33, 51-57.
8. Delmas, J., Schorr, O., Jamard, C., Gibbs, C., Trepo, C., Hantz, O. & Zoulim, F. (2002). Inhibitory effect of adefovir on viral DNA synthesis and covalently closed circular DNA formation in duck hepatitis B virus-infected hepatocytes in vivo and in vitro. Antimicrob Agents Chemother 46, 425-433.
9. Durantel, D., Carrouee-Durantel, S., Werle-Lapostolle, B., Brunelle, M. N., Pichoud, C., Trepo, C. & Zoulim, F. (2004). A new strategy for studying in vitro the drug susceptibility of clinical isolates of human hepatitis B virus. Hepatology 40, 855-864.
10. Engelke, M., Mills, K., Seitz, S., Simon, P., Gripon, P., Schnolzer, M. & Urban, S. (2006). Characterization of a hepatitis B and hepatitis delta virus receptor binding site. Hepatology 43, 750-760.
11. Galle, P. R., Schlicht, H. J., Kuhn, C. & Schaller, H. (1989). Replication of duck hepatitis B virus in primary duck hepatocytes and its dependence on the state of differentiation of the host cell. Hepatology 10, 459-465.
12. Galle, P. R., Hagelstein, J., Kommerell, B., Volkmann, M., Schranz, P. & Zentgraf, H. (1994). In vitro experimental infection of primary human hepatocytes with hepatitis B virus. Gastroenterology 106, 664-673.
13. Gao, W. & Hu, J. (2007). Formation of hepatitis B virus covalently closed circular DNA: removal of genome-linked protein. J Virol 81, 6164-6174.
14. Gripon, P., Diot, C., Theze, N., Fourel, I., Loreal, O., Brechot, C. & Guguen-Guillouzo, C. (1988a). Hepatitis B virus infection of adult human hepatocytes cultured in the presence of dimethyl sulfoxide. J Virol 62, 4136-4143.
15. Gripon, P., Diot, C., Thézé, N., Fourel, I., Loreal, O., Bréchot, C. & Guguen-Guillouzo, C. (1988b). Hepatitis B virus infection of adult human hepatocytes cultured in the presence of dimethyl sulfoxide. J Virol 62, 4136-4143.
16. Gripon, P., Diot, C. & Guguen-Guillouzo, C. (1993). Reproducible high level infection of cultured adult human hepatocytes by hepatitis virus: effect of polyethylen glycol on adsorption and penetration. Virology 192, 534-540.
17. Gripon, P., Rumin, S., Urban, S., Le Seyec, J., Glaise, D., Cannie, I., Guyomard, C., Lucas, J., Trepo, C. & Guguen-Guillouzo, C. (2002). Infection of a human hepatoma cell line by hepatitis B virus. Proc Natl Acad Sci U S A 99, 15655-15660.
18. Guillouzo, A., Corlu, A., Aninat, C., Glaise, D., Morel, F. & Guguen-Guillouzo, C. (2007). The human hepatoma HepaRG cells: a highly differentiated model for studies of liver metabolism and toxicity of xenobiotics. Chem Biol Interact 168, 66-73.
19. Guo, H., Jiang, D., Zhou, T., Cuconati, A., Block, T. M. & Guo, J. T. (2007). Characterization of the intracellular deproteinized relaxed circular DNA of hepatitis B virus: an intermediate of covalently closed circular DNA formation. J Virol 81, 12472-12484.
20. Hannoun, C., Horal, P. & Lindh, M. (2000). Long-term mutation rates in the hepatitis B virus genome. J Gen Virol 81, 75-83.
21. Köck, J., Nassal, M., MacNelly, S., Baumert, T. F., Blum, H. E. & von Weizsacker, F. (2001). Efficient infection of primary tupaia hepatocytes with purified human and woolly monkey hepatitis B virus. J Virol 75, 5084-5089.
22. Köck, J., Baumert, T. F., Delaney, W. E., IV, Blum, H. E. & von Weizsacker, F. (2003). Inhibitory effect of adefovir and lamivudine on the initiation of hepatitis B virus infection in primary tupaia hepatocytes. Hepatology 38, 1410-1418.
23. Lambert, V., Fernholz, D., Sprengel, R., Fourel, I., Deleage, G., Wildner, G., Peyret, C., Trepo, C., Cova, L. & Will, H. (1990). Virus-neutralizing monoclonal antibody to a conserved epitope on the duck hepatitis B virus pre-S protein. J Virol 64, 1290-1297.
24. Lee, K. D., Kuo, T. K., Whang-Peng, J., Chung, Y. F., Lin, C. T., Chou, S. H., Chen, J. R., Chen, Y. P. & Lee, O. K. (2004). In vitro hepatic differentiation of human mesenchymal stem cells. Hepatology 40, 1275-1284.
25. Mason, W. S., Seal, G. & Summers, J. (1980). Virus of Pekin ducks with structural and biological relatedness to human hepatitis B virus. J Virol 36, 829-836.
26. Mizuguchi, T., Mitaka, T., Hirata, K., Oda, H. & Mochizuki, Y. (1998). Alteration of expression of liver-enriched transcription factors in the transition between growth and differentiation of primary cultured rat hepatocytes. J Cell Physiol 174, 273-284.
27. Osiowy, C., Giles, E., Tanaka, Y., Mizokami, M. & Minuk, G. Y. (2006). Molecular evolution of hepatitis B virus over 25 years. J Virol 80, 10307-10314.
28. Parent, R. & Beretta, L. (2008). Translational control plays a prominent role in the hepatocytic differentiation of HepaRG liver progenitor cells. Genome Biol 9, R19.
29. Pugh, J. C. & Summers, J. W. (1989). Infection and uptake of duck hepatitis B virus by duck hepatocytes maintained in the presence of dimethyl sulfoxide. Virology 172, 564-572.
30. Rumin, S., Gripon, P., Le Seyec, J., Corral-Debrinski, M. & Guguen-Guillouzo, C. (1996). Long-term productive episomal hepatitis B virus replication in primary cultures of adult human hepatocytes infected in vitro. J Viral Hepat 3, 227-238.
31. Schorr, O., Borel, C., Trepo, C., Zoulim, F. & Hantz, O. (2006). Effects of liver growth factors on hepadnavirus replication in chronically infected duck hepatocytes. J Hepatol 44, 842-847.
32. Schulze, A., Gripon, P. & Urban, S. (2007). Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycans. Hepatology 46, 1759-1768.
33. Seeger, C. & Mason, W. S. (2000). Hepatitis B virus biology. Microbiol Mol Biol Rev 64, 51-68.
34. Sells, M. A., Chen, M. & Acs, G. (1987). Production of hepatitis B virus particles in hepG2 cells transfected with cloned hepatitis B virus DNA. Proc Natl Acad Sci U S A 84, 1005-1009.
35. Summers, J., Smith, P. M. & Horwich, A. L. (1990). Hepadnavirus envelope proteins regulate covalently closed circular DNA amplification. J Virol 64, 2819-2824.
36. Talarmin, H., Rescan, C., Cariou, S., Glaise, D., Zanninelli, G., Bilodeau, M., Loyer, P., Guguen-Guillouzo, C. & Baffet, G. (1999). The mitogen-activated protein kinase kinase extracellular signal-regulated kinase cascade activation is a key signalling pathway involved in the regulation of G1 phase progression in proliferating hepatocytes. Mol Cell Biol 19, 6003-6011.
37. Tang, H. & McLachlan, A. (2001). Transcriptional regulation of hepatitis B virus by nuclear hormone receptors is a critical determinant of viral tropism. Proc Natl Acad Sci U S A 98, 1841-1846.
38. Tang, H. & McLachlan, A. (2002). Avian and mammalian hepadnaviruses have distinct transcription factor requirements for viral replication. J Virol 76, 7468-7472.
39. Tang, H., Banks, K. E., Anderson, A. L. & McLachlan, A. (2001). Hepatitis B virus transcription and replication. Drug News Perspect 14, 325-334.
40. Turin, F., Borel, C., Benchaib, M., Kay, T., Jamard, C., Guguen-Guillouzo, C., Trepo, C. & Hantz, O. (1996). n-Butyrate, a cell cycle blocker, inhibits early amplification of duck hepatitis B virus covalently closed circular DNA after in vitro infection of duck hepatocytes. J Virol 70, 2691-2696.
41. Tuttleman, J. S., Pourcel, C. & Summers, J. W. (1986a). Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells. Cell 47, 451-460.
42. Tuttleman, J. S., Pugh, J. C. & Summers, J. W. (1986b). In vitro experimental infection of primary duck hepatocyte cultures with duck hepatitis B virus. J Virol 58, 17-25.
43. Werle-Lapostolle, B., Bowden, S., Locarnini, S., Wursthorn, K., Petersen, J., Lau, G., Trepo, C., Marcellin, P., Goodman, Z., Delaney, W. E., IV, Xiong, S., Brosgart, C. L., Chen, S. S., Gibbs, C. S. & Zoulim, F. (2004). Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy. Gastroenterology 126, 1750-1758.
44. Zoulim, F., Saputelli, J. & Seeger, C. (1994). Woodchuck hepatitis virus X protein is required for viral infection in vivo. J Virol 68, 2026-2030.